Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Recent studies have demonstrated a correlation between low vitamin D status and high mortality in septic patients.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Assessment of 28-day survival of patients with sepsis based on vitamin D status: a hospital-based prospective cohort study in Indonesia

Source: Article title.

The patients were included if they were ≥ 18 years of age and the patients or their guardians agreed to participate and meet the criteria for sepsis.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Full studies

Assessment of 28-day survival of patients with sepsis based on vitamin D status: a hospital-based prospective cohort study in Indonesia

Cohort study · The Pan African Medical Journal · 2023

Original publication title

Assessment of 28-day survival of patients with sepsis based on vitamin D status: a hospital-based prospective cohort study in Indonesia

Rizka Humardewayanti Asdie; Deshinta Putri Mulya; Maria Nainggolan

Copyright: Rizka Humardewayanti Asdie et al.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Deficient vitamin D levels, especially 25(OH)D concentrations below 8.1 ng/mL, were associated with higher 28-day mortality in septic patients. A 25(OH)D cutoff level of 8.1 ng/mL predicted mortality in 92.6% of this cohort. The mean survival of patients with vitamin D levels of < 8.1 ng/mL was 9 days (median: 6 days), and the mean survival of patients with vitamin D levels of ≥ 8.1 ng/mL was 14.8 days (median: 10 days) We observed shorter survival among patients with low vitamin D levels (< 8.1 ng/mL).

An extract from the source publication. Read it in context.

At a glance

Study background

What background does the paper provide?

Sepsis is a common condition and a major cause of morbidity and mortality. The documented incidence of sepsis worldwide is 1.8 million cases annually [1]. The case-fatality rate depends on the setting and severity, reaching 30% for sepsis, 50% for severe sepsis, and 80% for septic shock [2]. Vitamin D receptors are expressed in nearly all cells in the body, and the activating enzyme 1-alpha-hydroxylase is expressed in many tissue types. Vitamin D receptors are expressed in immune cells involved in both the innate and adaptive immune responses.

A form of vitamin D, 1,25-dihydroxyvitamin D3, appears to serve as a modulator of the immune system [3Not reported5]. There is growing evidence of a close relationship between vitamin D deficiency and various systemic disorders that increase morbidity and mortality in the general population [6].

Vitamin D deficiency was reportedly common in hospitalized patients, particularly critically ill patients. The incidence of vitamin D deficiency in critically ill patients ranges from 26% to 82%. Otherwise, vitamin D deficiency was common in critically ill patients (69%), but it was not an independent risk factor for mortality [7]. It may exacerbate existing immune and metabolic dysfunction in critically ill patients, leading to worse outcomes. A report by Ginde et al. found that vitamin D deficiency was associated with increased sepsis severity in emergency department patients hospitalized for suspected infections [8].

The purpose of this study was to investigate the clinical outcomes of septic patients with extremely low 25(OH)D concentrations (< 8.1 ng/mL), to demonstrate the relationship between vitamin D status and mortality, and to describe 28-day survival of septic patients with very low vitamin D levels (<8.1 ng/mL).

Source: Introduction Source: Introduction

Study methods

What methods does the paper describe?

Study design and setting: this study used an observational prospective cohort in the intensive care unit and internal medicine ward. This hospital-based study was conducted during 11 months with patients admitted to Dr. Sardjito Hospital, a tertiary care and teaching hospital in Yogyakarta, Indonesia from December 2018 to October 2019.

Study population: patients with the diagnosis of sepsis were considered for enrollment. The criteria used for the diagnosis of sepsis were adopted from the 2016 Third International Consensus Definition of Sepsis and Septic Shock [9]. The patients were included if they were ≥ 18 years of age and the patients or their guardians agreed to participate and meet the criteria for sepsis. Patients were excluded if microbiological and chemical data were lacking. Levels of 25(OH)D were measured in septic patients within 24 hours of admission.

The sample size was calculated using the sample size formula used in a comparative survival study intended to find the incidence rate in septic patients. The minimum sample for each group was 23 samples. All patients received empirical antibiotics upon diagnosis according to the hospital practice guideline. The antibiotics were escalated or de-escalated according to culture reports. Other treatments (standard supportive treatment, fluid resuscitation, vasoactive drugs, medical and technological interventions) were conducted according to “Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016” [1] (Figure 1).

Figure 1

study design

Figure image at the original source: open the original paper. This file is not included in this text import.

Data collection: baseline demographic data (age, gender, and body mass index), comorbidities, SOFA scores, and primary sources of infection were recorded. Clinical and laboratory variables obtained within 24 hours of hospital admission were complete blood count, serum creatinine, albumin, cultures, and 25(OH)D. All tests were performed by routine methods employed at biochemistry laboratory of Dr. Sardjito Hospital. Patients enrolled in the study were followed until ICU or hospital death or hospital discharge. Three investigators assed the patient for the eligibility for inclusion in the study.

All the data were revised by two senior investigators (RHA, DPM), if any problem was detected, patient history was evaluated. All patients were followed up for 28 days since sepsis diagnosed. Surviving patients were censored after 28 days of follow-up.

Laboratory analysis: 25(OH) vitamin D is considered the best parameter for the definition of vitamin D status. Serum 25(OH)D concentrations were assessed using the VIDAS 25(OH) Vitamin D Total assay (IFCC-EUROLAB). The assay´s limit of detection for 25(OH)D is 8.1 ng/mL, with a reportable range of 8.1 to 126 ng/mL [10]. Diagnoses of comorbidities and the source of infection were established according to the clinical and laboratory criteria. Blood cultures were processed with the BACTEC system at the Dr. Sardjito Hospital microbiology laboratory according to the Clinical Laboratory Standards Institute (CLSI).

The Sequential Organ Failure Assessment (SOFA) was used to assess the severity of organ dysfunction in septic patients using PaO2, platelet count, creatinine level, and bilirubin level data. Albumin was examined by spectrophotometry using the bromocresol green reagent on the Roche Cobas 6000 instrument in the clinical pathology laboratory of Dr. Sardjito Hospital. Dr. Sardjito Hospital, the academic medical center hospital of Gadjah Mada University, has been accredited by Joint Commission International (JCI) since 2014.

Definition of vitamin D: according to the Endocrine Society Clinical Practice Guidelines, vitamin D deficiency was defined as a serum 25(OH)D level of 0.0 to 19.9 ng/mL, insufficiency as 20.00 to 29.9 ng/mL, and sufficiency as ≥ 30 ng/mL. The minimum desirable serum level of 25(OH)D is ≥ 30 ng/mL [11]. Studies examining 25(OH)D deficiency in intensive care units have used different cutoff levels for critically ill septic patients. In our study, we used a 25(OH)D cut-off level of < 8.1 ng/mL, which was the lowest threshold of our detection test.

Because of the high rate of very low vitamin D levels in critically ill septic patients and its presumed strong association with worse clinical prognosis, a group of patients with very low vitamin D levels (< 8.1 ng/mL), was identified and analyzed as the exposure group.

Endpoint: the primary endpoint was clinical outcome defined as death within 28-days following sepsis (28-day mortality). Surviving patients were censored after 28 days of follow-up.

Statistical analysis: the Kolmogorov-Smirnov test was used to evaluate the distribution of variables. Continuous variables are expressed as means ±standard deviation (SD). Continuous variables were compared using t-tests for normally distributed data and Mann-Whitney tests for non-normally distributed data. Nominal variables, such as gender and other comorbidities, were analyzed using Chi-squared or Fisher exact tests. Vitamin D status was determined by serum 25(OH)D levels. For statistical comparison, we categorized the patients into two groups: vitamin D levels < 8.1 ng/mL and vitamin D levels ≥ 8.1 ng/mL (according to the lowest threshold of our detection test).

SPSS software (SPSS version 22) was used for statistical analysis. A survival comparison between the two groups was accomplished using the Kaplan-Meier estimation. Cox regression analysis was used to determine the hazard ratio. The multivariate Cox regression model retained any covariates associated with 28-day mortality (p < 0.25) in the univariate Cox regression analysis. For all tests, p < 0.05 was considered statistically significant.

Ethical consideration: the study was approved by the Medical and Health Research Ethics Committee of the Faculty of Medicine, Public Health, and Nursing at Gadjah Mada University and granted the ethical clearance letter of KE/FK/1049/EC/2019. All subjects or their guardians have received informed consent and agreed to participate in the study as shown by their signing in the informed consent forms.

Source: Methods Source: Methods Source: Methods Source: Methods Source: Methods Source: Methods Source: Methods Source: Methods Source: Methods

Discussion

This study aims to evaluate the vitamin D status of septic patients at Dr. Sardjito Hospital and describe 28-day survival with very low vitamin D levels (< 8.1 ng/mL). This study used a 25(OH)D cutoff level of 8.1 ng/mL to categorize patients into two groups (vitamin D < 8.1 ng/mL and ≥ 8.1 ng/mL). The results showed that 28 patients (32%) with sepsis had deficient vitamin D levels (< 8.1 ng/mL) and 60 patients (68%) with sepsis had vitamin D levels ≥ 8.1 ng/mL.

De Pascale et al. reported that 53% of septic patients had undetectable vitamin D levels (vitamin D < 7 ng/mL) [12]. The mean survival of patients with vitamin D levels of < 8.1 ng/mL was 9 days (median: 6 days), and the mean survival of patients with vitamin D levels of ≥ 8.1 ng/mL was 14.8 days (median: 10 days).

This study sought to determine whether vitamin D levels and 28-day survival of septic patients were correlated. In this study, vitamin D levels of < 8.1 ng/mL were associated with a higher mortality rate than those of =8.1 ng/mL (92% vs. 65%). These results are consistent with those of several previous studies, which reported that patients with sepsis who had low vitamin D levels had higher mortality rates compared with patients with sepsis who had higher vitamin D levels [12Not reported14].

This study demonstrated that a vitamin D level of 8.1 ng/mL was the best cutoff to identify patients with sepsis at a higher risk of death. In this prospective cohort study, vitamin D concentrations of < 8.1 ng/mL were associated with higher mortality. Several studies have reported results consistent with our findings, demonstrating similar significant associations [12,13,15Not reported18]. A systematic review and meta-analysis conducted by Upala et al. (2015) showed a significant relationship between vitamin D deficiency and sepsis [19].

In another systematic review and meta-analysis, de Haan et al. (2014) reported that vitamin D deficiency increased the risk of sepsis and death in critically ill patients [19,20].

Previous research has indicated that vitamin D receptors are expressed in almost all body cells, and its activating enzyme 1-alpha-hydroxylase is expressed in many tissues. Vitamin D regulates the innate and adaptive immune systems; thus, vitamin D deficiency can lead to dysregulation of the immune systems [7,19,20]. The innate and adaptive immune systems are regulated by vitamin D levels, which are related to the production of potent antibacterial peptides such as cathelicidin (LL-37) and ß-defensin-2.

In humans, cathelicidin shows potent activity against bacteria (including mycobacteria), viruses, and fungi [21]. In previous studies, cathelicidin levels tended to be low in patients with sepsis and positively correlated with 25(OH)D levels. This finding was confirmed in a cohort study by Leaf et al., in which 121 critical patients with low 25(OH)D levels on the first day of treatment in an ICU had low levels of cathelicidin antimicrobial protein-18 (hCAP18), which was also associated with high mortality rates in these patients [22,23].

In vitro research on macrophages infected with Mycobacterium tuberculosis revealed an elevation in endogenous antimicrobial cathelicidin peptides and an escalation in the killing process of microorganisms. In addition, vitamin D deficiency led to disorders of macrophage maturation, which disrupted their production of surface antigens, lysosomal enzymes, and H2O2, thereby inhibiting their antimicrobial function [24].

This study has several limitations. First, we only assessed the relationship and survival. We did not assess the causal relationship between vitamin D deficiency and mortality. In addition, this research was conducted only at Dr. Sardjito Hospital (a single center) with relatively small sample size. However, this research provides a foundation for conducting larger-scale research or clinical trial research in the future.

Source: Discussion Source: Discussion Source: Discussion Source: Discussion Source: Discussion

Conclusion: What is known about this topic

  • Sepsis is a potentially life-threatening condition caused by the body´s response to an infection;

  • Vitamin D deficiency is reportedly common in hospitalized patients, particularly critically ill patients;

  • Vitamin D receptors are expressed in immune cells involved in both the innate and adaptive immune responses.

Source: What is known about this topic

Conclusion: What this study adds

  • Sepsis is a common condition and a significant cause of morbidity and mortality;

  • The average survival was 9 days for patients with vitamin D levels < 8.1 ng/mL (median: 6 days) compared with 14 days for those with vitamin D levels ≥8.1 ng/mL (median: 10 days);

  • Vitamin D levels of < 8.1 ng/mL were associated with a higher mortality rate than those of ≥ 8.1 ng/mL (92% vs. 65%).

Source: What this study adds

Results

General characteristics of the study population: a total of the 88 included patients, 41 were men (46.6%) and 47 were women (53.4%), with a mean age at the admission of 56.09 ±16.82 years. The mean SOFA score was 7.26±3.6 and the mean ± SD 25(OH)D concentration was 15.25±9.14 ng/mL. The most frequent infection was pulmonary infection (n= 41, 46.6%). The most frequently used empirical antibiotic was cephalosporin (39.8%). Positive blood cultures were found in 33% of patients. Septic shock was encountered in 56 patients (63.6%), and acute kidney injury was encountered in 45 patients (51.1%).

The 28-day mortality rate of the entire study population was 73.9%. There were no significant differences regarding age, BMI, disease severity (according to the Sequential Organ Failure Assessment), albumin, comorbidities, blood culture, and septic shock between the two groups (Table 1).

Table 1

demographic and clinical characteristics based on vitamin D levels

VariableTotal study populationVitamin D <8.1 ng/mLVitamin D ≥8.1 ng/mLp-value
n= 88n=28n =60
Age, years (mean±SD)56.09±16.8251.36±17.6358.30±16.100.71
GenderMale n (%)41(46.6)8 (28)33 (55)Not reported
Female n (%)47(53.4)20 (71.4)27 (45)Not reported
BMI, kg/m2(mean±SD)20.92±4.3320.71±4.821.02±4.10.77
SOFA score(mean±SD)7.26±3.66.21±3.27.75±3.60.08
Albumin, mg/dL(mean±SD)2.56±0.632.6±0.692.5±0.600.30
Comorbidities N (%)< 2 comorbidities43(48.9)12 (42.9)31(51.7)0.44
≥ 2 comorbidities45(51.1)16 (57.1)29 (48.3)Not reported
Source of infection n(%)1 source of infection59(67)15 (53.6)44 (73.3)0.06
≥ 2 sources of infection29(33)13 (46.4)16 (26.7)Not reported
Empiric antibiotic n (%)Penicillin1(1.1)01 (1.7)Not reported
Cephalosporin35(39.8)9 (32.1)26 (43)Not reported
Carbapenem23(26.1)6 (21.4)17 (28.3)Not reported
Quinolone1(1)01 (1.7)Not reported
Antibiotic combination28(31.8)13(46.4)15 (25)Not reported
Positive blood culture29(33)9 (32.1)20 (33.3)0.91
Septic shock n(%)56(63.6)17(60.7)39 (65)0.69
AKI n (%)45(51.1)18(35.7)25 (58.3)0.48

Abbreviations: BMI, body mass index; SOFA, sequential organ failure assessment; AKI, acute kidney injury.

Mortality: only vitamin D levels < 8.1 ng/mL on admission (HR 1.90, 95%CI 1.14-3.15, p=0.01), pulmonary infection (HR 1.93, 95% CI 1.03-3.63, p=0.04), and septic shock (HR 1.75, 95% CI 1.03-2.97, p=0.03) were significantly associated with mortality. Multivariate Cox regression analysis was performed to identify factors independently associated with 28-day mortality in septic patients. Vitamin D levels of < 8.1 ng/mL (HR1.95, 95% CI 1.15-3.29, p = 0.01) and the presence of septic shock (HR1.94, 95% CI 1.09-3.46, p=0.02) were significantly associated with increased with mortality (Table 2).

Table 2

Cox regression analysis

VariableBivariateMultivariate
HR (CI 95 %)p-valueHR (CI 95 %)p-value
Age (years)≥651.19 (0.69 to 2.05)0.52
<65Ref
GenderMale1.07 (0.65 to 1.74)0.78
femaleRef
25(OH)D (ng/mL)<8.11.90 (1.14 to 3.15)0.01*1.95 (1.15 to 3.29)0.01*
≥8.1Ref
Albumin (g/dL)<3.51.94 (0.60 to 6.19)0.26
≥3.5Ref
ComorbiditiesHeart failure0.89 (0.50 to 1.60)0.71
Diabetes1.11 (0.63 to 1.96)0.70
Stroke0.66 (0.30 to 1.46)0.31
COPD1.10 (0.57 to 2.10)0.77
CKD0.94 (0.54 to 1.64)0.84
Cirrhosis1.51 (0.79 to 2.90)0.211.87 (0.94 to 3.71)0.71
Malignancy1.36 (0.83 to 2.22)0.211.19 (0.73 to 1.960.47
≥2 comorbidities1.02 (0.62 to 1.66)0.93
<2 comorbiditiesRef
Source of infectionPulmonary1.93 (1.03 to 3.63)0.04*1.58 (0.80 to 3.13)0.18
Urinary tract0.73 (0.43 to 1.22)0.230.71 (0.40 to 1.24)0.23
Skin soft tissue0.95 (0.49 to 1.82)0.89
Intra-abdominal0.65 (0.23 to 1.79)0.40
Infection0.48 (0.06 to 3.47)0.46
≥2 sources of infection1.11 (0.66 to 1.85)0.67
1 source of infectionRef
Positive blood culture1.55 (0.91 to 2.52)0.101.59 (9.47 to 2.66)0.07
Septic shock1.75 (1.03 to 2.97)0.03*1.94 (1.09 to 3.46)0.02*
AKI0.68 (0.42 to 1.12)0.33

Abbreviations: 25(OH)D, serum 25α-hydroxyvitamin D; CKD, chronic kidney disease; SOFA, sequential organ failure assessment; AKI, acute kidney injury. *indicate a significant p-value.

Twenty-eight-day survival analysis: for the 28-day observation period, 26 of the 28 patients with vitamin D levels of < 8.1 ng/mL died (92.6%), whereas 39 of the 60 patients with vitamin D levels of ≥ 8.1 ng/mL died (65%). This difference was statistically significant (p=0.006). The overall 28-day survival was 26.1%. The survival rate in patients with vitamin D levels of < 8.1 ng/mL was lower than that in patients with vitamin D levels of ≥ 8.1 ng/mL (7.14% vs. 35%).

The more prolonged average survival was noted among patients with vitamin D levels of ≥ 8.1 ng/mL. The mean survival of patients with vitamin D levels of < 8.1 ng/mL was 9 days (median: 6 days), and the mean survival of patients with vitamin D levels of ≥ 8.1 ng/mL was 14.8 days (median: 10 days) (p=0.008) (Figure 2).

Figure 2

Kaplan-Meier curve for septic patients with 25(OH) D < 8.1 ng/mL

Figure image at the original source: open the original paper. This file is not included in this text import.
Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results

Conclusion

Deficient vitamin D levels, especially 25(OH)D concentrations below 8.1 ng/mL, were associated with higher 28-day mortality in septic patients. A 25(OH)D cutoff level of 8.1 ng/mL predicted mortality in 92.6% of this cohort. The mean survival of patients with vitamin D levels of < 8.1 ng/mL was 9 days (median: 6 days), and the mean survival of patients with vitamin D levels of ≥ 8.1 ng/mL was 14.8 days (median: 10 days) We observed shorter survival among patients with low vitamin D levels (< 8.1 ng/mL).

What is known about this topic

  • Sepsis is a potentially life-threatening condition caused by the body´s response to an infection;

  • Vitamin D deficiency is reportedly common in hospitalized patients, particularly critically ill patients;

  • Vitamin D receptors are expressed in immune cells involved in both the innate and adaptive immune responses.

What this study adds

  • Sepsis is a common condition and a significant cause of morbidity and mortality;

  • The average survival was 9 days for patients with vitamin D levels < 8.1 ng/mL (median: 6 days) compared with 14 days for those with vitamin D levels ≥8.1 ng/mL (median: 10 days);

  • Vitamin D levels of < 8.1 ng/mL were associated with a higher mortality rate than those of ≥ 8.1 ng/mL (92% vs. 65%).

Source: Conclusion Source: Conclusion Source: Conclusion
Authors’ abstract

Introduction

sepsis is a potentially life-threatening condition caused by the body´s response to an infection. Recent studies have demonstrated a correlation between low vitamin D status and high mortality in septic patients. This study aims to evaluate the vitamin D status of septic patients at Dr. Sardjito Hospital and describe 28-day survival with very low vitamin D levels (< 8.1 ng/mL).

Methods

this prospective cohort study was conducted in the intensive care unit and internal medicine ward at Dr. Sardjito Hospital in septic patients admitted between December 2018 and October 2019. Vitamin D [25(OH)D] was prospectively measured within 24 hours of admission. Data collection used SPSS software for statistical analysis. In addition, the sample size was calculated using the sample size formula used in a comparative survival study intended to find the incidence rate in septic patients. The minimum sample for each group is 23 samples.

Results

sepsis-related mortality was higher in patients with low vitamin D. The analysis included 88 septic patients during the study period. The mean age was 56.09 ± 16.82 years and the proportion of males was 46.6%. 26 of 28 patients with vitamin D levels < 8.1 ng/mL died (92.6%), whereas 39 of 60 patients with vitamin D levels ≥ 8.1 ng/mL (65%) died. Multivariate Cox regression analysis showed that vitamin D concentrations < 8.1 ng/mL at admission (p=0.01) and sepsis shock (p=0.02) were associated with increased sepsis mortality.

The hazard ratio of 28-day mortality was 1.95 (95% CI 1.15-3.29, p=0.01) for vitamin D levels < 8.1 ng/mL. The average survival was 9 days for patients with vitamin D levels < 8.1 ng/mL (median: 6 days) compared with 14 days for those with vitamin D levels ≥ 8.1 ng/mL (median: 10 days).

Conclusion

low serum vitamin D levels (< 8.1ng/mL) at admission were associated with increased 28-day mortality in septic patients.

Read the full paper

Introduction

Sepsis is a common condition and a major cause of morbidity and mortality. The documented incidence of sepsis worldwide is 1.8 million cases annually [1]. The case-fatality rate depends on the setting and severity, reaching 30% for sepsis, 50% for severe sepsis, and 80% for septic shock [2]. Vitamin D receptors are expressed in nearly all cells in the body, and the activating enzyme 1-alpha-hydroxylase is expressed in many tissue types. Vitamin D receptors are expressed in immune cells involved in both the innate and adaptive immune responses.

A form of vitamin D, 1,25-dihydroxyvitamin D3, appears to serve as a modulator of the immune system [3Not reported5]. There is growing evidence of a close relationship between vitamin D deficiency and various systemic disorders that increase morbidity and mortality in the general population [6].

Vitamin D deficiency was reportedly common in hospitalized patients, particularly critically ill patients. The incidence of vitamin D deficiency in critically ill patients ranges from 26% to 82%. Otherwise, vitamin D deficiency was common in critically ill patients (69%), but it was not an independent risk factor for mortality [7]. It may exacerbate existing immune and metabolic dysfunction in critically ill patients, leading to worse outcomes. A report by Ginde et al. found that vitamin D deficiency was associated with increased sepsis severity in emergency department patients hospitalized for suspected infections [8].

The purpose of this study was to investigate the clinical outcomes of septic patients with extremely low 25(OH)D concentrations (< 8.1 ng/mL), to demonstrate the relationship between vitamin D status and mortality, and to describe 28-day survival of septic patients with very low vitamin D levels (<8.1 ng/mL).

Methods

Study design and setting: this study used an observational prospective cohort in the intensive care unit and internal medicine ward. This hospital-based study was conducted during 11 months with patients admitted to Dr. Sardjito Hospital, a tertiary care and teaching hospital in Yogyakarta, Indonesia from December 2018 to October 2019.

Study population: patients with the diagnosis of sepsis were considered for enrollment. The criteria used for the diagnosis of sepsis were adopted from the 2016 Third International Consensus Definition of Sepsis and Septic Shock [9]. The patients were included if they were ≥ 18 years of age and the patients or their guardians agreed to participate and meet the criteria for sepsis. Patients were excluded if microbiological and chemical data were lacking. Levels of 25(OH)D were measured in septic patients within 24 hours of admission.

The sample size was calculated using the sample size formula used in a comparative survival study intended to find the incidence rate in septic patients. The minimum sample for each group was 23 samples. All patients received empirical antibiotics upon diagnosis according to the hospital practice guideline. The antibiotics were escalated or de-escalated according to culture reports. Other treatments (standard supportive treatment, fluid resuscitation, vasoactive drugs, medical and technological interventions) were conducted according to “Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016” [1] (Figure 1).

Figure 1

study design

Figure image at the original source: open the original paper. This file is not included in this text import.

Data collection: baseline demographic data (age, gender, and body mass index), comorbidities, SOFA scores, and primary sources of infection were recorded. Clinical and laboratory variables obtained within 24 hours of hospital admission were complete blood count, serum creatinine, albumin, cultures, and 25(OH)D. All tests were performed by routine methods employed at biochemistry laboratory of Dr. Sardjito Hospital. Patients enrolled in the study were followed until ICU or hospital death or hospital discharge. Three investigators assed the patient for the eligibility for inclusion in the study.

All the data were revised by two senior investigators (RHA, DPM), if any problem was detected, patient history was evaluated. All patients were followed up for 28 days since sepsis diagnosed. Surviving patients were censored after 28 days of follow-up.

Laboratory analysis: 25(OH) vitamin D is considered the best parameter for the definition of vitamin D status. Serum 25(OH)D concentrations were assessed using the VIDAS 25(OH) Vitamin D Total assay (IFCC-EUROLAB). The assay´s limit of detection for 25(OH)D is 8.1 ng/mL, with a reportable range of 8.1 to 126 ng/mL [10]. Diagnoses of comorbidities and the source of infection were established according to the clinical and laboratory criteria. Blood cultures were processed with the BACTEC system at the Dr. Sardjito Hospital microbiology laboratory according to the Clinical Laboratory Standards Institute (CLSI).

The Sequential Organ Failure Assessment (SOFA) was used to assess the severity of organ dysfunction in septic patients using PaO2, platelet count, creatinine level, and bilirubin level data. Albumin was examined by spectrophotometry using the bromocresol green reagent on the Roche Cobas 6000 instrument in the clinical pathology laboratory of Dr. Sardjito Hospital. Dr. Sardjito Hospital, the academic medical center hospital of Gadjah Mada University, has been accredited by Joint Commission International (JCI) since 2014.

Definition of vitamin D: according to the Endocrine Society Clinical Practice Guidelines, vitamin D deficiency was defined as a serum 25(OH)D level of 0.0 to 19.9 ng/mL, insufficiency as 20.00 to 29.9 ng/mL, and sufficiency as ≥ 30 ng/mL. The minimum desirable serum level of 25(OH)D is ≥ 30 ng/mL [11]. Studies examining 25(OH)D deficiency in intensive care units have used different cutoff levels for critically ill septic patients. In our study, we used a 25(OH)D cut-off level of < 8.1 ng/mL, which was the lowest threshold of our detection test.

Because of the high rate of very low vitamin D levels in critically ill septic patients and its presumed strong association with worse clinical prognosis, a group of patients with very low vitamin D levels (< 8.1 ng/mL), was identified and analyzed as the exposure group.

Endpoint: the primary endpoint was clinical outcome defined as death within 28-days following sepsis (28-day mortality). Surviving patients were censored after 28 days of follow-up.

Statistical analysis: the Kolmogorov-Smirnov test was used to evaluate the distribution of variables. Continuous variables are expressed as means ±standard deviation (SD). Continuous variables were compared using t-tests for normally distributed data and Mann-Whitney tests for non-normally distributed data. Nominal variables, such as gender and other comorbidities, were analyzed using Chi-squared or Fisher exact tests. Vitamin D status was determined by serum 25(OH)D levels. For statistical comparison, we categorized the patients into two groups: vitamin D levels < 8.1 ng/mL and vitamin D levels ≥ 8.1 ng/mL (according to the lowest threshold of our detection test).

SPSS software (SPSS version 22) was used for statistical analysis. A survival comparison between the two groups was accomplished using the Kaplan-Meier estimation. Cox regression analysis was used to determine the hazard ratio. The multivariate Cox regression model retained any covariates associated with 28-day mortality (p < 0.25) in the univariate Cox regression analysis. For all tests, p < 0.05 was considered statistically significant.

Ethical consideration: the study was approved by the Medical and Health Research Ethics Committee of the Faculty of Medicine, Public Health, and Nursing at Gadjah Mada University and granted the ethical clearance letter of KE/FK/1049/EC/2019. All subjects or their guardians have received informed consent and agreed to participate in the study as shown by their signing in the informed consent forms.

Results

General characteristics of the study population: a total of the 88 included patients, 41 were men (46.6%) and 47 were women (53.4%), with a mean age at the admission of 56.09 ±16.82 years. The mean SOFA score was 7.26±3.6 and the mean ± SD 25(OH)D concentration was 15.25±9.14 ng/mL. The most frequent infection was pulmonary infection (n= 41, 46.6%). The most frequently used empirical antibiotic was cephalosporin (39.8%). Positive blood cultures were found in 33% of patients. Septic shock was encountered in 56 patients (63.6%), and acute kidney injury was encountered in 45 patients (51.1%).

The 28-day mortality rate of the entire study population was 73.9%. There were no significant differences regarding age, BMI, disease severity (according to the Sequential Organ Failure Assessment), albumin, comorbidities, blood culture, and septic shock between the two groups (Table 1).

Table 1

demographic and clinical characteristics based on vitamin D levels

VariableTotal study populationVitamin D <8.1 ng/mLVitamin D ≥8.1 ng/mLp-value
n= 88n=28n =60
Age, years (mean±SD)56.09±16.8251.36±17.6358.30±16.100.71
GenderMale n (%)41(46.6)8 (28)33 (55)Not reported
Female n (%)47(53.4)20 (71.4)27 (45)Not reported
BMI, kg/m2(mean±SD)20.92±4.3320.71±4.821.02±4.10.77
SOFA score(mean±SD)7.26±3.66.21±3.27.75±3.60.08
Albumin, mg/dL(mean±SD)2.56±0.632.6±0.692.5±0.600.30
Comorbidities N (%)< 2 comorbidities43(48.9)12 (42.9)31(51.7)0.44
≥ 2 comorbidities45(51.1)16 (57.1)29 (48.3)Not reported
Source of infection n(%)1 source of infection59(67)15 (53.6)44 (73.3)0.06
≥ 2 sources of infection29(33)13 (46.4)16 (26.7)Not reported
Empiric antibiotic n (%)Penicillin1(1.1)01 (1.7)Not reported
Cephalosporin35(39.8)9 (32.1)26 (43)Not reported
Carbapenem23(26.1)6 (21.4)17 (28.3)Not reported
Quinolone1(1)01 (1.7)Not reported
Antibiotic combination28(31.8)13(46.4)15 (25)Not reported
Positive blood culture29(33)9 (32.1)20 (33.3)0.91
Septic shock n(%)56(63.6)17(60.7)39 (65)0.69
AKI n (%)45(51.1)18(35.7)25 (58.3)0.48

Abbreviations: BMI, body mass index; SOFA, sequential organ failure assessment; AKI, acute kidney injury.

Mortality: only vitamin D levels < 8.1 ng/mL on admission (HR 1.90, 95%CI 1.14-3.15, p=0.01), pulmonary infection (HR 1.93, 95% CI 1.03-3.63, p=0.04), and septic shock (HR 1.75, 95% CI 1.03-2.97, p=0.03) were significantly associated with mortality. Multivariate Cox regression analysis was performed to identify factors independently associated with 28-day mortality in septic patients. Vitamin D levels of < 8.1 ng/mL (HR1.95, 95% CI 1.15-3.29, p = 0.01) and the presence of septic shock (HR1.94, 95% CI 1.09-3.46, p=0.02) were significantly associated with increased with mortality (Table 2).

Table 2

Cox regression analysis

VariableBivariateMultivariate
HR (CI 95 %)p-valueHR (CI 95 %)p-value
Age (years)≥651.19 (0.69 to 2.05)0.52
<65Ref
GenderMale1.07 (0.65 to 1.74)0.78
femaleRef
25(OH)D (ng/mL)<8.11.90 (1.14 to 3.15)0.01*1.95 (1.15 to 3.29)0.01*
≥8.1Ref
Albumin (g/dL)<3.51.94 (0.60 to 6.19)0.26
≥3.5Ref
ComorbiditiesHeart failure0.89 (0.50 to 1.60)0.71
Diabetes1.11 (0.63 to 1.96)0.70
Stroke0.66 (0.30 to 1.46)0.31
COPD1.10 (0.57 to 2.10)0.77
CKD0.94 (0.54 to 1.64)0.84
Cirrhosis1.51 (0.79 to 2.90)0.211.87 (0.94 to 3.71)0.71
Malignancy1.36 (0.83 to 2.22)0.211.19 (0.73 to 1.960.47
≥2 comorbidities1.02 (0.62 to 1.66)0.93
<2 comorbiditiesRef
Source of infectionPulmonary1.93 (1.03 to 3.63)0.04*1.58 (0.80 to 3.13)0.18
Urinary tract0.73 (0.43 to 1.22)0.230.71 (0.40 to 1.24)0.23
Skin soft tissue0.95 (0.49 to 1.82)0.89
Intra-abdominal0.65 (0.23 to 1.79)0.40
Infection0.48 (0.06 to 3.47)0.46
≥2 sources of infection1.11 (0.66 to 1.85)0.67
1 source of infectionRef
Positive blood culture1.55 (0.91 to 2.52)0.101.59 (9.47 to 2.66)0.07
Septic shock1.75 (1.03 to 2.97)0.03*1.94 (1.09 to 3.46)0.02*
AKI0.68 (0.42 to 1.12)0.33

Abbreviations: 25(OH)D, serum 25α-hydroxyvitamin D; CKD, chronic kidney disease; SOFA, sequential organ failure assessment; AKI, acute kidney injury. *indicate a significant p-value.

Twenty-eight-day survival analysis: for the 28-day observation period, 26 of the 28 patients with vitamin D levels of < 8.1 ng/mL died (92.6%), whereas 39 of the 60 patients with vitamin D levels of ≥ 8.1 ng/mL died (65%). This difference was statistically significant (p=0.006). The overall 28-day survival was 26.1%. The survival rate in patients with vitamin D levels of < 8.1 ng/mL was lower than that in patients with vitamin D levels of ≥ 8.1 ng/mL (7.14% vs. 35%).

The more prolonged average survival was noted among patients with vitamin D levels of ≥ 8.1 ng/mL. The mean survival of patients with vitamin D levels of < 8.1 ng/mL was 9 days (median: 6 days), and the mean survival of patients with vitamin D levels of ≥ 8.1 ng/mL was 14.8 days (median: 10 days) (p=0.008) (Figure 2).

Figure 2

Kaplan-Meier curve for septic patients with 25(OH) D < 8.1 ng/mL

Figure image at the original source: open the original paper. This file is not included in this text import.

Discussion

This study aims to evaluate the vitamin D status of septic patients at Dr. Sardjito Hospital and describe 28-day survival with very low vitamin D levels (< 8.1 ng/mL). This study used a 25(OH)D cutoff level of 8.1 ng/mL to categorize patients into two groups (vitamin D < 8.1 ng/mL and ≥ 8.1 ng/mL). The results showed that 28 patients (32%) with sepsis had deficient vitamin D levels (< 8.1 ng/mL) and 60 patients (68%) with sepsis had vitamin D levels ≥ 8.1 ng/mL.

De Pascale et al. reported that 53% of septic patients had undetectable vitamin D levels (vitamin D < 7 ng/mL) [12]. The mean survival of patients with vitamin D levels of < 8.1 ng/mL was 9 days (median: 6 days), and the mean survival of patients with vitamin D levels of ≥ 8.1 ng/mL was 14.8 days (median: 10 days).

This study sought to determine whether vitamin D levels and 28-day survival of septic patients were correlated. In this study, vitamin D levels of < 8.1 ng/mL were associated with a higher mortality rate than those of =8.1 ng/mL (92% vs. 65%). These results are consistent with those of several previous studies, which reported that patients with sepsis who had low vitamin D levels had higher mortality rates compared with patients with sepsis who had higher vitamin D levels [12Not reported14].

This study demonstrated that a vitamin D level of 8.1 ng/mL was the best cutoff to identify patients with sepsis at a higher risk of death. In this prospective cohort study, vitamin D concentrations of < 8.1 ng/mL were associated with higher mortality. Several studies have reported results consistent with our findings, demonstrating similar significant associations [12,13,15Not reported18]. A systematic review and meta-analysis conducted by Upala et al. (2015) showed a significant relationship between vitamin D deficiency and sepsis [19].

In another systematic review and meta-analysis, de Haan et al. (2014) reported that vitamin D deficiency increased the risk of sepsis and death in critically ill patients [19,20].

Previous research has indicated that vitamin D receptors are expressed in almost all body cells, and its activating enzyme 1-alpha-hydroxylase is expressed in many tissues. Vitamin D regulates the innate and adaptive immune systems; thus, vitamin D deficiency can lead to dysregulation of the immune systems [7,19,20]. The innate and adaptive immune systems are regulated by vitamin D levels, which are related to the production of potent antibacterial peptides such as cathelicidin (LL-37) and ß-defensin-2.

In humans, cathelicidin shows potent activity against bacteria (including mycobacteria), viruses, and fungi [21]. In previous studies, cathelicidin levels tended to be low in patients with sepsis and positively correlated with 25(OH)D levels. This finding was confirmed in a cohort study by Leaf et al., in which 121 critical patients with low 25(OH)D levels on the first day of treatment in an ICU had low levels of cathelicidin antimicrobial protein-18 (hCAP18), which was also associated with high mortality rates in these patients [22,23].

In vitro research on macrophages infected with Mycobacterium tuberculosis revealed an elevation in endogenous antimicrobial cathelicidin peptides and an escalation in the killing process of microorganisms. In addition, vitamin D deficiency led to disorders of macrophage maturation, which disrupted their production of surface antigens, lysosomal enzymes, and H2O2, thereby inhibiting their antimicrobial function [24].

This study has several limitations. First, we only assessed the relationship and survival. We did not assess the causal relationship between vitamin D deficiency and mortality. In addition, this research was conducted only at Dr. Sardjito Hospital (a single center) with relatively small sample size. However, this research provides a foundation for conducting larger-scale research or clinical trial research in the future.

Conclusion

Deficient vitamin D levels, especially 25(OH)D concentrations below 8.1 ng/mL, were associated with higher 28-day mortality in septic patients. A 25(OH)D cutoff level of 8.1 ng/mL predicted mortality in 92.6% of this cohort. The mean survival of patients with vitamin D levels of < 8.1 ng/mL was 9 days (median: 6 days), and the mean survival of patients with vitamin D levels of ≥ 8.1 ng/mL was 14.8 days (median: 10 days) We observed shorter survival among patients with low vitamin D levels (< 8.1 ng/mL).

What is known about this topic

  • Sepsis is a potentially life-threatening condition caused by the body´s response to an infection;

  • Vitamin D deficiency is reportedly common in hospitalized patients, particularly critically ill patients;

  • Vitamin D receptors are expressed in immune cells involved in both the innate and adaptive immune responses.

What this study adds

  • Sepsis is a common condition and a significant cause of morbidity and mortality;

  • The average survival was 9 days for patients with vitamin D levels < 8.1 ng/mL (median: 6 days) compared with 14 days for those with vitamin D levels ≥8.1 ng/mL (median: 10 days);

  • Vitamin D levels of < 8.1 ng/mL were associated with a higher mortality rate than those of ≥ 8.1 ng/mL (92% vs. 65%).

Acknowledgments

This study was financially supported by are search grant from Gadjah Mada University. We want to thank the Dr. Sardjito Hospital Indonesia trust staff and patients for their help in the recruitment process and their participation in this study. The authors would like to thank the staff at the Medical Faculty Laboratory of Gadjah Mada University and Dr. Sardjito Hospital for their valuable assistance with sample processing. We also thank Lihartanadi J, Yurista M, and Khairunisa A for their assistance with data collection and entry.

Cite this article: Rizka Humardewayanti Asdie et al. Assessment of 28-day survival of patients with sepsis based on vitamin D status: a hospital-based prospective cohort study in Indonesia. Pan African Medical Journal. 2023;45(76). 10.11604/pamj.2023.45.76.36336

Competing interests

The authors declare no competing interests.

Authors’ contributions

Conception and study design: Rizka Humardewayanti Asdie. Data collection, data analysis and interpretation, and manuscript drafting: Maria Nainggolan. Manuscript revision: Deshinta Putri Mulya, Rizka Humardewayanti Asdie. Guarantor of the study: Rizka Humardewayanti Asdie. All authors read and approved the final version of the manuscript.

1 Daniels R Surviving the first hours in sepsis: getting the basics right (an intensivist´s perspective) J Antimicrob Chemother 2011 Apr66 Suppl 2 ii11 23 21398303 10.1093/jac/dkq515
2 Jawad I Lukšic I Rafnsson SB Assessing available information on the burden of sepsis: global estimates of incidence, prevalence and mortality J Glob Heal 2012 Jun2 1 010404 10.7189/jogh.02.010404 PMC3484761 23198133
3 de Paula FJA Rosen CJ Vitamin D safety and requirements Arch Biochem Biophys 2012 Jul1523 1 64 72 Epub 2011 Dec 9 22179017 10.1016/j.abb.2011.12.002 PMC3311750
4 Veldman CM Cantorna MT DeLuca HF Expression of 1,25-Dihydroxyvitamin D3 Receptor in the Immune System Arch Biochem Biophys 2000 Feb15374 2 334 8 10666315 10.1006/abbi.1999.1605
5 Holick MF Chen TC Vitamin D deficiency: a worldwide problem with health consequences Am J Clin Nutr 2008 Apr187 4 1080S 1086S 18400738 10.1093/ajcn/87.4.1080S
6 Matysiak-Lusnia K Vitamin D in critically ill patients Anestezjol Intens Ter 2016 Jul1948 3 201 7 10.5603/AIT.a2016.0034 27444873
7 Aygencel G Turkoglu M Tuncel AF Candir BA Bildaci YD Pasaoglu H Is Vitamin D Insufficiency Associated with Mortality of Critically Ill Patients? Crit Care Res Pract 2013 2013 856747 Epub 2013 Dec 25 24455224 10.1155/2013/856747 PMC3886570
8 Ginde AA Camargo CA Shapiro NI Vitamin D Insufficiency and Sepsis Severity in Emergency Department Patients With Suspected Infection Acad Emerg Med 2011 May18 5 551 4 Epub 2011 Apr 22 21518095 10.1111/j.1553-2712.2011.01047.x
9 Singer M Deutschman CS Seymour CW Shankar-Hari M Annane D Bauer M et al The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA 2016 Feb23315 8 801 10 26903338 10.1001/jama.2016.0287 PMC4968574
10 Moreau E Bächer S Mery S Goff C Le Piga N Vogeser M Hausmann M Cavalier E Performance characteristics of the VIDAS® 25-OH Vitamin D Total assay-comparison with four immunoassays and two liquid chromatography-tandem mass spectrometry methods in a multicentric study Clin Chem Lab Med 2016 Jan54 1 45 53 26124054 10.1515/cclm-2014-1249
11 Holick MF Binkley NC Bischoff-Ferrari HA Gordon CM Hanley DA Heaney RP Murad MH Weaver CM Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline J Clin Endocrinol Metab 2011 Jul96 7 1911 30 Epub 2011 Jun 6 21646368 10.1210/jc.2011-0385
12 De Pascale G Vallecoccia MS Schiattarella A Di Gravio V Cutuli SL Bello G et al Clinical and microbiological outcome in septic patients with extremely low 25-hydroxyvitamin D levels at initiation of critical care Clin Microbiol Infect 2016 May22 5 456e7 456.e13 Epub 2015 Dec 23 10.1016/j.cmi.2015.12.015 26721785
13 Moraes RB Friedman G Wawrzeniak IC Marques LS Nagel FM Lisboa TC Czepielewski MA Vitamin D deficiency is independently associated with mortality among critically ill patients Clinics 2015 May70 5 326 32 Epub 2015 May 1 26039948 10.6061/clinics/2015(05)04 PMC4449478
14 Trongtrakul K Feemuchang C Prevalence and association of vitamin D deficiency and mortality in patients with severe sepsis Int J Gen Med 2017 Nov810 415 421 eCollection 2017 29184435 10.2147/IJGM.S147561 PMC5685096
15 Venkatram S Chilimuri S Adrish M Salako A Patel M Diaz-Fuentes G Vitamin D deficiency is associated with mortality in the medical intensive care unit Crit Care 2011 15 6 R292 Epub 2011 Dec 10 22152332 10.1186/cc10585 PMC3388639
16 Moromizato T Litonjua AA Braun AB Gibbons FK Giovannucci E Christopher KB Association of Low Serum 25-Hydroxyvitamin D Levels and Sepsis in the Critically Ill Crit Care Med 2014 Jan42 1 97 107 23982028 10.1097/CCM.0b013e31829eb7af
17 Upala S Sanguankeo A Permpalung N Significant association between vitamin D deficiency and sepsis: a systematic review and meta-analysis BMC Anesthesiol 2015 Dec415 1 84 26041306 10.1186/s12871-015-0063-3 PMC4455341
18 de Haan K Groeneveld AJ de Geus HR Egal M Struijs A Vitamin D deficiency as a risk factor for infection, sepsis and mortality in the critically ill: systematic review and meta-analysis Crit Care 2014 Dec518 6 660 25475621 10.1186/s13054-014-0660-4 PMC4277653
19 Baeke F Takiishi T Korf H Gysemans C Mathieu C Vitamin D: modulator of the immune system Curr Opin Pharmacol 2010 Aug10 4 482 96 Epub 2010 Apr 27 20427238 10.1016/j.coph.2010.04.001
20 Adams JS Hewison M Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity Nat Clin Pract Endocrinol Metab 2008 Feb4 2 80 90 18212810 10.1038/ncpendmet0716 PMC2678245
21 Lee P Nair P Eisman JA Center JR Vitamin D deficiency in the intensive care unit: an invisible accomplice to morbidity and mortality? Intensive Care Med 2009 Dec1535 12 2028 19756497 10.1007/s00134-009-1642-x
22 Leaf DE Croy HE Abrahams SJ Raed A Waikar SS Cathelicidin antimicrobial protein, vitamin D, and risk of death in critically ill patients Crit Care 2015 Dec119 1 80 25887571 10.1186/s13054-015-0812-1 PMC4357206
23 Arnson Y Gringauz I Itzhaky D Amital H Vitamin D deficiency is associated with poor outcomes and increased mortality in severely ill patients QJM 2012 Jul1105 7 633 9 22331959 10.1093/qjmed/hcs014
24 Bouillon R Carmeliet G Verlinden L van Etten E Verstuyf A Luderer HF et al Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice Endocr Rev 2008 Oct29 6 726 76 Epub 2008 Aug 11 18694980 10.1210/er.2008-0004 PMC2583388
Publication and source details

Original title: Assessment of 28-day survival of patients with sepsis based on vitamin D status: a hospital-based prospective cohort study in Indonesia

Rizka Humardewayanti Asdie; Deshinta Putri Mulya; Maria Nainggolan

The Pan African Medical Journal · 2023

& Corresponding author: Maria Nainggolan, Department of Internal Medicine, Faculty of Medicine, Public Health and Nursing, Gadjah Mada University, Yogyakarta, Indonesia. marianainggolanh@gmail.comCopyright: Rizka Humardewayanti Asdie et al.2023https://creativecommons.org/licenses/by/4.0/The Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T06:30:52.365114+00:00

DOI: 10.11604/pamj.2023.45.76.36336 · PMC10474818